Join
Live feed
·
PRReleasevia Quantisnow
Diffusion Pharmaceuticals Inc. logo

Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

ByQuantisnow·Wall Street's wire, on your screen.
DFFN· Diffusion Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DFFN (Diffusion Pharmaceuticals Inc.) and more on Quantisnow.